Dogwood Therapeutics DWTX Issuance Costs Included In Accounts Payable And Accrued Expenses
Issuance Costs Included In Accounts Payable And Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept dwtx:IssuanceCostsIncludedInAccountsPayableAndAccruedExpenses.
The official record: Dogwood Therapeutics’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's issuance costs included in accounts payable and accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's issuance costs included in accounts payable and accrued expenses?
- Dogwood Therapeutics (DWTX) reported issuance costs included in accounts payable and accrued expenses of $26.57K in Q4 2025.
- What does issuance costs included in accounts payable and accrued expenses mean?
- Represents capital-raising costs that have been incurred but not yet paid in cash, recorded as liabilities. This metric provides a more accurate view of the total cost of financing activities by including accrued expenses. It is useful for reconciling the timing differences between accounting recognition and cash outflow.